誠志股份(000990.SZ):雲南漢盟取得工業大麻種植許可證
格隆匯4月9日丨誠志股份(000990.SZ)公佈,為進一步完善生命科技領域的產業結構,公司於2019年完成了對雲南漢盟製藥有限公司(“雲南漢盟”)的股權收購及增資,併成為其控股股東,間接持有其49%的股權。
2020年4月9日,雲南漢盟取得了雲南省尋甸回族彝族自治縣公安局禁毒大隊核發的《雲南省工業大麻種植許可證》。
工業大麻種植需要一定的週期,預計不會對公司近期業績產生重大影響。
截至目前,雲南漢盟正在籌建自有工業大麻原料基地,並按原計劃有序推進市場與技術研發工作。與此同時,公司雲南漢盟項目目前廠房已封頂、設備的安裝進展順利,研發方面取得較大進展。預計可以按照原計劃於2020年內投產。正式投產後,公司可以生產高純度CBD晶體(99.5%以上),還可以提供不含THC的廣譜系油,並掌握規模化提取CBDV、CBC等十幾種高價值大麻素的核心技術。
雲南漢盟取得《工業大麻種植許可證》後,有助於進一步拓寬公司工業大麻提取產業鏈,增加後期工業大麻的原料來源,增強綜合競爭力,為公司生命科技板塊的長期發展提供有力的支持和保障。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.